Literature DB >> 21382501

Ex vivo T cell depletion of allogeneic PBSC as acute and chronic GVHD prophylaxis after myeloablative HCT: time to reconsider?

Vincent T Ho.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21382501     DOI： 10.1016/j.bbmt.2011.02.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  3 in total

1.  Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.

Authors:  Jenna D Goldberg; Junting Zheng; Ravin Ratan; Trudy N Small; Kuan-Chi Lai; Farid Boulad; Hugo Castro-Malaspina; Sergio A Giralt; Ann A Jakubowski; Nancy A Kernan; Richard J O'Reilly; Esperanza B Papadopoulos; James W Young; Marcel R M van den Brink; Glenn Heller; Miguel-Angel Perales
Journal:  Leuk Lymphoma       Date:  2017-01-10

2.  CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.

Authors:  Ankit Anand; Prathima Anandi; Natasha A Jain; Kit Lu; Neil Dunavin; Christopher S Hourigan; Robert Q Le; Puja D Chokshi; Sawa Ito; David F Stroncek; Marianna Sabatino; A John Barrett; Minoo Battiwalla
Journal:  Support Care Cancer       Date:  2015-07-21       Impact factor: 3.603

3.  Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants.

Authors:  J D Goldberg; J Zheng; H Castro-Malaspina; A A Jakubowski; G Heller; M R M van den Brink; M-A Perales
Journal:  Bone Marrow Transplant       Date:  2012-07-02       Impact factor: 5.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.